This early-phase study tests a new treatment called ACIT-1, which uses immune cells from a healthy donor to help fight cancer. The main goal is to find the safest dose and see if it can boost the body's immune response against tumors. The trial includes 34 adults with pancreatic …
Phase: PHASE1, PHASE2 • Sponsor: Cancer Vaccines Limited • Aim: Disease control
Last updated May 17, 2026 03:18 UTC